Incidence of vaccine preventable pneumococcal invasive infections and blood culture practices in Italy.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMID 15752836)

Published in Vaccine on March 31, 2005

Authors

Fortunato D'Ancona1, Stefania Salmaso, Antonella Barale, Delia Boccia, Pier Luigi Lopalco, Caterina Rizzo, Monica Monaco, Marco Massari, Vittorio Demicheli, Annalisa Pantosti, Italian PNC-Euro working group

Author Affiliations

1: National Centre for Epidemiology, Surveillance and Health Promotion-Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.

Articles citing this

Molecular detection methods and serotyping performed directly on clinical samples improve diagnostic sensitivity and reveal increased incidence of invasive disease by Streptococcus pneumoniae in Italian children. J Med Microbiol (2008) 1.71

Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries. Eur J Clin Microbiol Infect Dis (2007) 1.05

Incidence of bacterial meningitis (2001-2005) in Lazio, Italy: the results of a integrated surveillance system. BMC Infect Dis (2009) 0.93

Epidemiologic impact of blood culture practices and antibiotic consumption on pneumococcal bacteraemia in children. Eur J Clin Microbiol Infect Dis (2008) 0.89

The status of invasive pneumococcal disease among children younger than 5 years of age in north-west Lombardy, Italy. BMC Infect Dis (2012) 0.87

A retrospective analysis of hospital discharge records for S. pneumoniae diseases in the elderly population of Florence, Italy, 2010-2012. Hum Vaccin Immunother (2014) 0.80

Burden of paediatric invasive pneumococcal disease in Europe, 2005. Epidemiol Infect (2006) 0.79

The burden of bacteremia and invasive diseases in children aged less than five years with fever in Italy. Ital J Pediatr (2015) 0.77

Serotype distribution, clonality and antimicrobial resistance of invasive pneumococcal isolates in a central Italian region: implications for vaccine strategies. Eur J Pediatr (2006) 0.75

Articles by these authors

Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med (2008) 13.35

PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J Virol (2006) 5.46

Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J (2005) 3.14

An autochthonous case of Zika due to possible sexual transmission, Florence, Italy, 2014. Euro Surveill (2016) 2.79

Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev (2008) 2.69

Systematic review exploring time trends in the association between educational attainment and risk of HIV infection in sub-Saharan Africa. AIDS (2008) 2.67

Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda. Emerg Infect Dis (2003) 2.61

The social determinants of tuberculosis: from evidence to action. Am J Public Health (2011) 2.58

Mitigation measures for pandemic influenza in Italy: an individual based model considering different scenarios. PLoS One (2008) 2.54

Livestock-associated methicillin-resistant Staphylococcus aureus in humans, Europe. Emerg Infect Dis (2011) 2.35

Quality of systematic reviews of economic evaluations in health care. JAMA (2002) 2.31

Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C. J Virol (2002) 2.26

Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study. PLoS Med (2011) 2.25

Resurgence of pertussis in Europe. Pediatr Infect Dis J (2005) 2.23

Close encounters in a pediatric ward: measuring face-to-face proximity and mixing patterns with wearable sensors. PLoS One (2011) 2.10

Treatment optimization and prediction of HCV clearance in patients with acute HCV infection. J Hepatol (2013) 2.04

Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev (2012) 2.03

A large outbreak of hepatitis E among a displaced population in Darfur, Sudan, 2004: the role of water treatment methods. Clin Infect Dis (2006) 1.80

Unintended events following immunization with MMR: a systematic review. Vaccine (2003) 1.75

Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study. Lancet Infect Dis (2010) 1.74

I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe. PLoS One (2011) 1.73

Complex traditional Chinese medicine for poststroke motor dysfunction: a systematic review. Stroke (2009) 1.69

Waterborne outbreak of Norwalk-like virus gastroenteritis at a tourist resort, Italy. Emerg Infect Dis (2002) 1.65

Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology (2009) 1.65

The mef(E)-carrying genetic element (mega) of Streptococcus pneumoniae: insertion sites and association with other genetic elements. Antimicrob Agents Chemother (2006) 1.64

Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study. Am J Gastroenterol (2002) 1.62

Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period. Vaccine (2010) 1.57

Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J Med Virol (2005) 1.57

Assessment of measles incidence, measles-related complications and hospitalisations during an outbreak in a southern Italian region. Vaccine (2005) 1.55

Transmission potential of chikungunya virus and control measures: the case of Italy. PLoS One (2011) 1.53

Tn2009, a Tn916-like element containing mef(E) in Streptococcus pneumoniae. Antimicrob Agents Chemother (2004) 1.52

African sleeping sickness in tourists returning from Tanzania: the first 2 Italian cases from a small outbreak among European travelers. Clin Infect Dis (2001) 1.49

Do changes in policy affect vaccine coverage levels? Results of a national study to evaluate childhood vaccination coverage and reasons for missed vaccination in Italy. Vaccine (2004) 1.48

Quality of economic evaluations in health care. BMJ (2002) 1.48

The macrolide resistance genes erm(B) and mef(E) are carried by Tn2010 in dual-gene Streptococcus pneumoniae isolates belonging to clonal complex CC271. Antimicrob Agents Chemother (2007) 1.46

Dietary intake of unsaturated fatty acids and age-related cognitive decline: a 8.5-year follow-up of the Italian Longitudinal Study on Aging. Neurobiol Aging (2005) 1.46

Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project. Eur J Pediatr (2010) 1.44

Eurogin 2010 roadmap on cervical cancer prevention. Int J Cancer (2011) 1.40

[Tobacco taxation is a public health measure]. Epidemiol Prev (2014) 1.39

Effect of duration of breastfeeding on neuropsychological development at 10 to 12 years of age in a cohort of healthy children. Dev Med Child Neurol (2012) 1.39

Persistent carriage and infection by multidrug-resistant Escherichia coli ST405 producing NDM-1 carbapenemase: report on the first Italian cases. J Clin Microbiol (2011) 1.38

Community-acquired methicillin-resistant Staphylococcus aureus ST398 infection, Italy. Emerg Infect Dis (2009) 1.32

Lactococcus garvieae endocarditis in a patient with colonic diverticulosis: first case report in Italy and review of the literature. New Microbiol (2012) 1.25

Age-prioritized use of antivirals during an influenza pandemic. BMC Infect Dis (2009) 1.24

Huangqi injection (a traditional Chinese patent medicine) for chronic heart failure: a systematic review. PLoS One (2011) 1.23

Trends for influenza-related deaths during pandemic and epidemic seasons, Italy, 1969-2001. Emerg Infect Dis (2007) 1.22

European Guidelines for Control and Prevention of Travel Associated Legionnaires' Disease: the Italian experience. Euro Surveill (2004) 1.18

Mechanisms of antibiotic resistance in Staphylococcus aureus. Future Microbiol (2007) 1.18

Update on screening and clinical diagnosis of meticillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents (2010) 1.16

An infectious disease model on empirical networks of human contact: bridging the gap between dynamic network data and contact matrices. BMC Infect Dis (2013) 1.14

Epidemiology and costs of herpes zoster: background data to estimate the impact of vaccination. Vaccine (2007) 1.14

Clinical, social and relational determinants of paediatric ambulatory drug prescriptions due to respiratory tract infections in Italy. Eur J Clin Pharmacol (2006) 1.14

An outbreak of hepatitis A in Puglia, Italy, 1996. Euro Surveill (1996) 1.12

Experimental studies of susceptibility of Italian Aedes albopictus to Zika virus. Euro Surveill (2016) 1.12

Diagnosis and management of pertussis. CMAJ (2005) 1.11

Clinical presentation of pertussis in unvaccinated and vaccinated children in the first six years of life. Pediatrics (2003) 1.11

Different transmission patterns in the early stages of the influenza A(H1N1)v pandemic: a comparative analysis of 12 European countries. Epidemics (2011) 1.10

Use of whole-blood samples in in-house bulk and single-cell antigen-specific gamma interferon assays for surveillance of Mycobacterium tuberculosis infections. Clin Vaccine Immunol (2007) 1.09

Methicillin-resistant Staphylococcus aureus necrotizing pneumonia. Emerg Infect Dis (2005) 1.07

The growing impact of HIV infection on the epidemiology of tuberculosis in England and Wales: 1999 2003. Thorax (2007) 1.05

Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15. Euro Surveill (2016) 1.04

Phenotypic and genotypic characterization of two penicillin-susceptible serotype 6B Streptococcus pneumoniae clones circulating in Italy. J Clin Microbiol (2003) 1.04

Methicillin-resistant Staphylococcus aureus ST398, Italy. Emerg Infect Dis (2010) 1.04

Complete genome sequence of a serotype 11A, ST62 Streptococcus pneumoniae invasive isolate. BMC Microbiol (2011) 1.03

Zinc metalloproteinase genes in clinical isolates of Streptococcus pneumoniae: association of the full array with a clonal cluster comprising serotypes 8 and 11A. Microbiology (2006) 1.03

Vaccine adverse event monitoring systems across the European Union countries: time for unifying efforts. Vaccine (2009) 1.02

Progress in Italy in control and elimination of measles and congenital rubella. Vaccine (2007) 1.02

Identification of a variant "Rome clone" of methicillin-resistant Staphylococcus aureus with decreased susceptibility to vancomycin, responsible for an outbreak in an intensive care unit. Microb Drug Resist (2004) 1.02

Evolution of erythromycin resistance in Streptococcus pneumoniae in Italy. J Antimicrob Chemother (2005) 1.01

Molecular characterization of spa type t127, sequence type 1 methicillin-resistant Staphylococcus aureus from pigs. J Antimicrob Chemother (2011) 1.01

Health burden and economic impact of measles-related hospitalizations in Italy in 2002-2003. BMC Public Health (2007) 1.01

Clonal spread of a vancomycin-resistant Enterococcus faecium strain among bloodstream-infecting isolates in Italy. J Clin Microbiol (2005) 1.00

ECS-3: a crystalline hybrid organic-inorganic aluminosilicate with open porosity. Angew Chem Int Ed Engl (2011) 1.00

Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries. PLoS One (2013) 1.00

Behavioural responses to influenza pandemics: what do we know? PLoS Curr (2009) 1.00

Estimated imported infections of Chikungunya and Dengue in Italy, 2008 to 2011. J Travel Med (2012) 0.99

Knowledge, attitude and practice in primary and secondary cervical cancer prevention among young adult Italian women. Vaccine (2012) 0.98

A persisting outbreak of hepatitis A in Puglia, Italy, 1996: epidemiological follow-up. Euro Surveill (1997) 0.98

Pneumococcal carriage in young children one year after introduction of the 13-valent conjugate vaccine in Italy. PLoS One (2013) 0.97

Inferring the potential success of pneumococcal vaccination in Italy: serotypes and antibiotic resistance of Streptococcus pneumoniae isolates from invasive diseases. Microb Drug Resist (2003) 0.97

Measles serological survey in the Italian population: interpretation of results using mixture model. Vaccine (2008) 0.97

Increase of pneumococcal serotype 19A in Italy is due to expansion of the piliated clone ST416/CC199. J Med Microbiol (2013) 0.97

New genetic element carrying the erythromycin resistance determinant erm(TR) in Streptococcus pneumoniae. Antimicrob Agents Chemother (2007) 0.97

Antibiotic-resistant invasive pneumococcal clones in Italy. J Clin Microbiol (2006) 0.96

I-MOVE multicentre case-control study 2010/11 to 2014/15: Is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination? Euro Surveill (2016) 0.96

Point mutations in wchA are responsible for the non-typability of two invasive Streptococcus pneumoniae isolates. Microbiology (2011) 0.96

Antibiotic use: the crystal ball for predicting antibiotic resistance. Clin Infect Dis (2005) 0.96

Pediatric sentinel surveillance of vaccine-preventable diseases in Italy. Pediatr Infect Dis J (2002) 0.95

[Hospitalisation associated with Rotavirus gastroenteritis in Italy, 2001-2003, evaluated by means of ICD9-CM diagnostic codes]. Ig Sanita Pubbl (2007) 0.95

New A/H3N2 influenza variant: a small genetic evolution but a heavy burden on the Italian population during the 2004-2005 season. J Clin Microbiol (2005) 0.94

Serotype distribution, antibiotic susceptibility, and genetic relatedness of Neisseria meningitidis strains recently isolated in Italy. Clin Infect Dis (2003) 0.94

A randomized trial of consensus interferon in combination with ribavirin as initial treatment for chronic hepatitis C. J Hepatol (2003) 0.94